Filing Flows › Merit Medical Systems (MMSI) › R&D spending
Merit Medical Systems (MMSI) R&D spending by quarter
Merit Medical Systems' R&D spending was $22.4M in Q3 2026 (third quarter 2026), -12% from Q2 2026. Over the last 7 quarters it ranged from $22.4M (Q3 2026) to $26.5M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $22.4M | -12% | -7% |
| Q2 2026 | $25.4M | +12% | +4% |
| Q1 2026 | $22.6M | -15% | +0.6% |
| Q4 2025 | $26.5M | +11% | — |
| Q3 2025 | $24.0M | -2% | — |
| Q2 2025 | $24.4M | +8% | — |
| Q1 2025 | $22.5M | — | — |
Q3 2026 at a glance
Merit Medical Systems, Q3 2026: revenue $416M (+8% year over year), operating margin 14.1%, net earnings $42.3M, operating cash flow $65.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Merit Medical Systems' R&D spending?
Merit Medical Systems' R&D spending was $22.4M in Q3 2026 (third quarter 2026), -12% from Q2 2026.
How has Merit Medical Systems' R&D spending changed?
Over the last 7 quarters it ranged from $22.4M (Q3 2026) to $26.5M (Q4 2025).